The region is accustomed to lockdowns, but New Delhi’s ban on high-speed internet is undermining the medical community’s ability to fight the pandemic.
An interesting article from Australia.
Australia is in an unusual situation, being at once potentially extremely self-reliant and in practice extremely vulnerable to disruptions in international trade.
Whereas disruptions could come from any one of many types of natural disasters or due to politics, I am glad to see that the Australians are seriously considering what it would require to maintain their civilization in the face of disruptions.
Ira Pastor, ideaXme life sciences ambassador, interviews Dr. Stanley Plotkin, Professor Emeritus at both Wistar Institute and the University of Pennsylvania and consultant to the vaccine industry.
Ira Pastor Comments:
Continue reading “Dr Stanley Plotkin: The Godfather of Vaccines” »
Scientists have — for the first time — shown how chemical triggers in the nervous system can amplify the pain experienced by mammals in response to certain stimuli.
The pain system probably evolved to alert them to life-threatening dangers. As they approach objects that are extremely hot or cold or are biting them, they experience intense pain — allowing them to get out of harm’s way.
But in certain diseases, that defence mechanism malfunctions and rather than providing a short, sharp shock — it produces long-term, chronic pain, seen with some conditions affecting humans such as neuropathies, arthritic pains or migraines.
With the curve finally flattening in the US, the ramping up of anti-viral and vaccine trials against SARS-CoV-2—the virus that causes Covid-19—and the launch of antibody tests to screen for previous infection, it seems like science is rapidly moving towards the end game. How exactly the Covid-19 pandemic will finally bugger off into history is still anyone’s guess, but virologists and public health experts generally agree that immunity is key—either through widespread safe and effective vaccination, or when enough of our population has recovered from infections and gained herd immunity.
Well. That’s the hand-waving, shruggie emoji, “eh who knows” short answer.
Like most processes in biology, immunity to SARS-CoV-2 is complex and mysterious, with results that could rapidly diverge into many possible futures. It’s partly why estimates of how long Covid-19 sticks around to wreak havoc can vary enormously, from months to years to…well, seasonal and forever, similar to the flu.
A full payout for Musk, who is also the majority owner and CEO of the SpaceX rocket maker, would surpass anything previously granted to US executives.
When Tesla unveiled Musk’s package in 2018, it said he could theoretically reap as much as $US55.8 billion if no new shares were issued. However, Tesla has since issued shares to compensate employees, and last year it sold $US2.7 billion in shares and convertible bonds.
The potential payout for Musk comes after Tesla said this month it would furlough all non-essential workers and implement salary cuts during a shutdown of its US production facilities because of the coronavirus outbreak. The pandemic has slashed US demand for cars and forced several other automakers to also furlough US workers.
How to read a popular chart of coronavirus cases by country.
Support Vox by joining the Video Lab at http://vox.com/join or making a one-time contribution: http://vox.com/contribute
https://www.youtube.com/watch?v=OQd_Yf0x_5I
Dr. Jason Williams discusses his decision to administer follistatin gene therapy, a myostatin inhibitor, to himself in 2015.
Visit Integrated Health Systems to learn more about follistatin gene therapy.
Continue reading “My Gene Therapy with Dr. Jason Williams” »
Medical experts are currently investigating a possible link between coronavirus and an inflammatory disease found among infants.
It follows a rise in children being admitted to hospital with the symptoms of Kawasaki disease, which include “multi-system inflammation” and flu-like symptoms.
